Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. - Test2 - elhamkhani - TriplyDB

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

http://www.wikidata.org/entity/Q35623673

about

The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Innate lymphoid cells in graft-versus-host disease Graft-versus-host disease biomarkers: omics and personalized medicine Advances in predicting acute GVHD Acute graft-versus-host disease: a bench-to-bedside update.NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.Protein calorie malnutrition, nutritional intervention and personalized cancer care.Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.Less (bacterial diversity) is more (deaths)Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantation.Recent advances in the management of graft-versus-host disease.Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.Intestinal microbiota-related effects on graft-versus-host disease.Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.Plasma biomarkers of lower gastrointestinal and liver acute GVHD.Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.Supporting information retrieval from electronic health records: A report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE)Advances in understanding the pathogenesis of graft-versus-host disease.Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells.Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation Role of the intestinal mucosa in acute gastrointestinal GVHD.The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation.Have we made progress in the treatment of GVHD?Discovery and validation of graft-versus-host disease biomarkers How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality Biomarker Panel for Chronic Graft-Versus-Host Disease.

P2860

Q26751265-B405FC77-A692-456E-A186-AD8FE53CFCDD Q26752528-557B87B9-C0F8-4017-B4C1-376800AADB9F Q26801315-88E853B7-024B-4DEC-99EE-778FA1174DDA Q26824540-F8A10A4A-4D5E-46F4-A9BF-07BBD1962A5F Q27021123-E5D3DA95-E9D1-432F-9C57-3EBC613E60F5 Q27687130-EEFB7C1A-0E9D-4C76-837A-2DE7D22C7987 Q28081289-4CBCF9A9-34BB-4483-8C4F-9972063484DB Q30278940-805EBBFC-6130-4A0B-B8CF-9DC6C4E1672F Q33618955-565D8731-C635-41D9-B81B-30625F11B1BB Q33809599-C88EA948-B9D5-464F-8ADB-9CA3A90A2581 Q33838584-50FBE041-2C33-42AE-9F80-9BFAED93CB2A Q33886907-4795C162-8649-4741-AF74-68FAA73208F2 Q34047945-B8BE82B9-95A8-4ECE-A0BC-A8FD96D5C9DD Q34093615-CBF704C1-9A31-465B-B6E5-743F024BEFE7 Q34325048-64D5AAB6-799A-4B13-AA4E-5B31945EB02D Q34428890-DA54C2BC-822B-47BE-8063-F32709251597 Q34626032-0C169C00-6E46-496D-910A-CC2382BB4223 Q34802425-2252A86C-083E-436E-A23E-252CA0FB25DB Q35022269-4571197B-3857-412E-BC2B-515F67444710 Q35120338-EA2F7045-5866-436E-8425-62582908E887 Q35180727-2D8223B7-E9D6-4FE3-9515-27DF40F1A9F4 Q35587907-82494466-21CF-4BF8-B95D-1909319D93E6 Q35820356-26AE8B0C-B97B-4C30-B5BF-4EECF9521BB1 Q35891657-F6C62B5B-4B38-4823-98E4-EE7C88C71852 Q35909700-8DBFD97F-2712-4BB5-87E4-E2B9075D6E87 Q35924262-C98E62F4-19A5-4180-84B6-C66EF520D5E4 Q35971439-62B6898C-4626-418E-8EF5-9901992E6A59 Q35975038-C5AD3A16-3F0F-4DC6-ABD4-581348A49F50 Q36039542-C49EC1C6-63B3-441F-86BA-6A2BAED42963 Q36055238-883F7DD3-E4E7-4322-8DF7-4A16BBB73DD8 Q36212428-D358BFD2-2928-400F-9DDF-0A82537D318F Q36264109-06CEF59E-11E6-4CC7-9A4E-46D7541317E6 Q36443057-AFF2A8AB-F794-40E3-8EEC-2387CC2A1814 Q36569667-E5C1E853-42AD-4AC0-AB11-B9D7E394DD8C Q36727862-B877A6C1-66FE-4C44-880B-B4BB3449582E Q36861714-F92CBA78-20C4-4464-9D9B-919ADE32C8F5 Q36904560-2DC49509-77D9-430A-98E4-4ECB152DCF7F Q36925951-23B5BFD9-B1EE-4AF9-BE63-2BD55D439DD4 Q37113096-EAFA161C-5286-4852-AC57-111DC123A858 Q37234820-BB644FBC-A868-4958-8B8A-4F6FFAF8E45C

P2860

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

http://www.wikidata.org/entity/Q35623673

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@ast

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@en

type

label

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@ast

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@en

prefLabel

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@ast

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@en

P1433

Q35623673-0852DD02-5EAA-41CE-8870-A0452AEFBA34

P1476

Q35623673-753603A8-67D4-483B-BC6E-CE19397FD04A

P2093

Q35623673-0B9BCD31-CA1E-4C9D-A56C-BE5BEF41917E

Q35623673-0BBD08F3-5177-4A24-83DA-C19B6DDB0A01

Q35623673-296D6B3C-796B-454F-AA68-4B3285F5988E

Q35623673-39365C77-C6B0-42CB-AF96-019F89852635

Q35623673-3E949365-4E78-41F7-A871-735FCFC272D4

Q35623673-426B0062-7B56-46D2-A7E2-3BDB8DF9EE19

Q35623673-591A658B-DD64-44CF-BE7A-E87BF7ACFDA6

Q35623673-60B2DA83-8F27-4487-AFA1-67AB72B6F192

Q35623673-89519A8B-9EF4-4CCE-BD8D-A1E89388E1FB

Q35623673-D0810139-2CAF-47E6-841D-7E8D10D9C392

P2860

Q35623673-0131E78E-9C2A-4577-80E4-77D715C39725

Q35623673-2CF86055-E653-4281-82C2-329D23A8C0B6

Q35623673-32E49BEE-F814-4417-9783-5DD3B9CE5A45

Q35623673-3BC2583E-5088-49CC-9C52-B7A31CEBCF30

Q35623673-45E3126F-587E-40BA-91DB-2F32F6069093

Q35623673-4983AFDD-D2B1-4687-94B1-F2897BD37DE7

Q35623673-4D193199-B9FB-4BC0-8569-8A26526C4DFC

Q35623673-558C4C6D-D790-4F0B-80AF-E53CC107059F

Q35623673-77C1979B-9791-4D09-A610-54A13F6901A2

Q35623673-80337430-D4D7-4914-BDAC-F07E395959E7

P304

Q35623673-E15CB246-B06C-4381-BF72-388DFDF5E0F7

P31

Q35623673-091BC7D5-99E2-4EAB-9A22-145E98E9FFFA

P356

Q35623673-43F9A6B6-99F9-4BF0-90D2-35A4F9BBEEEA

P407

Q35623673-AEB64381-B60F-4171-98E1-978A3E32E547

P433

Q35623673-AD8C8615-445C-45EC-B5F8-9342A0852903

P478

Q35623673-873F05D4-A833-410E-B916-2283297A35E4

P50

Q35623673-018D0553-0B40-44C2-B5C7-2CB65B03B8BA

Q35623673-086BFDA4-17A0-4D62-9094-86696C11B23C

Q35623673-BEFA90EF-94B2-42A2-9D13-686BC6CA67D6

P577

Q35623673-30A04856-0C2D-49E3-A831-0A0E8ACED30D

P5875

Q35623673-BF1CDDD7-0E86-4135-892F-112C9F762D21

P698

Q35623673-FCEA52F7-0BE6-4589-BB55-4FEF06ECDAC5

P921

Q35623673-43085530-721A-4DE2-B174-89D86C4F2DE5

P932

Q35623673-01B4E6CB-1600-4853-8312-D1E217C4968B

P356

BLOOD-2011-08-375006

P1433

P1476

Regenerating islet-derived 3-a ...... nal graft-versus-host disease.

@en

P2093

Alice Chin

http://www.w3.org/2001/XMLSchema#string

Elisabeth Huber

http://www.w3.org/2001/XMLSchema#string

Ernst Holler

http://www.w3.org/2001/XMLSchema#string

James L M Ferrara

http://www.w3.org/2001/XMLSchema#string

Joel K Greenson

http://www.w3.org/2001/XMLSchema#string

Karin Landfried

http://www.w3.org/2001/XMLSchema#string

Koichi Akashi

http://www.w3.org/2001/XMLSchema#string

Mark Vander Lugt

http://www.w3.org/2001/XMLSchema#string

Pavan Reddy

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of human palladin, a microfilament-associated protein

Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene

HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells

Elafin is a biomarker of graft-versus-host disease of the skin

Symbiotic bacteria direct expression of an intestinal bactericidal lectin

Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria

Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

Graft-versus-host disease treatment: predictors of survival.

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.

P304

6702-6708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-08-375006

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Andrew C. Harris

Sophie Paczesny

P577

2011-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51699615

http://www.w3.org/2001/XMLSchema#string

P698

21979939

http://www.w3.org/2001/XMLSchema#string

P921

P932

3242723

http://www.w3.org/2001/XMLSchema#string